Gland Pharma Share Price Target 2025, 2027, 2030, 2040, and 2050

If you are wondering which share will be best for investment in recent times then you should know about Gland Pharma Share Price Target 2025, 2030, 2040, and 2050. Today in this article we will explain the basic idea about the Gland Pharma Share Price Target 2025, 2027, 2030, 2040, and 2050. Based on our research and expert advice, this blog is about the company’s growth, performance, etc.

In this article, we will describe the company’s financial growth, the business policy of the company, the shareholding pattern of the company, and the forecast share price yearly. Gland Pharma’s Share Price Target is a trading share in the share market. We use expert research and analysis to understand the Gland Pharma Share Price Target. This article may be useful to those who want to invest in this share. Let’s explore the Gland Pharma Share Price Target from 2025 to 2050.

Read More: Coal India share price target 2025

Introduction

Founded in Hyderabad, India, in 1978, Gland Pharma Company specializes in pharmaceuticals. The production and distribution of injections and some medications is Gland Pharma Company’s primary business activity. Because there is constant demand in the medical field day and night, Gland Pharma’s share price is consistently high.

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer [HK1] of small-volume liquid parenteral products, to become one of the largest and fastest-growing generic injectables manufacturing companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets.

Overview

The Gland Pharma Company manufactures its injectables and pharmaceuticals mostly in Europe, but also in India. The US, Canada, South Africa, Australia, and other countries are among the countries to which the company sends its items. In addition, the Gland Pharma Company produces a range of medical supplies, including as ampoules, small vials, and syringes.

Company Name	Gland Pharma Limited
Market Cap	₹31,826Crore
Face Value	₹1
Book Value	₹546
P/B	3.35
52 Week High	₹6,885
52 Week Low	₹1475
DIV. YIELD	1.07%

Financial Data Analysis

To comprehend its performance, we need to look at the company’s PE ratio, return on equity, current ratio, and return on assets. These characteristics will be covered in the following section. These ratios likewise influence Gland Pharma target share price.

PE Ratio	Return On Assets (ROA)	Current Ratio	Return On Equity (ROE)
28.85	11%	8.05	12.55

Gland Pharma Share Price Target 2024

The Gland Pharma Company is able to produce new medications and equipment in response to market demand because it consistently prioritizes research and development. Gland Pharma Company supplies medical supplies and medications to approximately 1500 public and private hospitals, clinics, and assisted living facilities. Gland Pharma Company makes significant financial profits from several hospitals and health facilities.

Year	Gland Pharma Share Price Target 2024
1st Price Target	1,795
2nd Price Target	2,175

Gland Pharma Share Price Target 2025

The United States accounts for a sizable portion of Gland Pharma Company’s business revenue. The United States accounts for more than 60% of the company’s rise in sales. For research and development purposes, the United States is a particularly developed nation; for this reason, pharmaceutical companies have placed a greater emphasis on this area.

Year	Gland Pharma Share Price Target 2025
1st Price Target	2,235
2nd Price Target	2,475

Gland Pharma Share Price Target 2027

The entire product line of Gland Pharma Company is exported from India. All items sold by Gland Pharma Company are exported from Pashamylaram Hyderabad, Penems Hyderabad, and Dundigal Hyderabad.

Year	Gland Pharma Share Price Target 2027
1st Price Target	2,825
2nd Price Target	3,095

Gland Pharma Share Price Target 2030

Since Gland Pharma is a pharmaceutical company, there is always a demand for its products. In light of the Covid pandemic, pharmaceutical companies have emerged as indispensable entities for all. The need for prescription medications and standard medical supplies (such as glucometers, pulse oximeters, and nebulizers) also skyrocketed. Consequently, there is a rise in demand for Gland Pharma Company. Additionally, Gland Pharma Company increased its yearly profit above 15%.

Year	Gland Pharma Share Price Target 2030
1st Price Target	3,765
2nd Price Target	3,975

Gland Pharma Share Price Target 2040

Gland Pharma’s growth in revenue and net profit over the last five years should also be taken into consideration when estimating the share price for 2040. Gland Pharma Company’s net profit margin ranges from 20 to 22%, and its sales growth is likewise not too shabby at 20%.

Year	Gland Pharma Share Price Target 2040
1st Price Target	6,135
2nd Price Target	6,375

Gland Pharma Share Price Target 2050

It is speculative to forecast the share price of IDBI Bank for 2050 because of variables including business performance, prevailing economic conditions, and industry developments. It is preferable to concentrate on short-term estimates and professional analysis for long-term investments.

Year	Gland Pharma Share Price Target 2050
1st Price Target	11,135
2nd Price Target	11,375

Advantages and Disadvantages Of Gland Pharma

Every share offers various benefits as well as drawbacks. Thus, the following list of benefits and drawbacks equally applies to the Gland Pharma Share Price Target.

Advantages

• Due to the company’s strong performance and its respectable promoter holding capacity of 55.56%, a number of well-qualified investors have expressed interest in purchasing Gland Pharma shares.
• Being a pharmaceutical company, Gland Pharma Company enjoys great demand in the industry. Due to Gland Pharma Company’s affiliation with numerous government and private hospitals, its demand has also surged.
• Due to the fact that Gland Pharma Company exports its goods to South Africa, the United States, and Canada, a sizable portion of its growing revenue originates from overseas investors.

Disadvantages

• There is always a possibility of intense competition in the pharmaceutical sector because there are numerous pharmaceutical companies operating there.

FAQs

Conclusion

We hope https://pricepredictionhub.com/ will provide you with some fundamental knowledge on the Gland Pharma Share Price Target. We make sure that, over time, the Gland Pharma Share Price Target may rise to an extremely high position by conducting the necessary research and consulting with specialists. Gland Pharma is mostly associated with producing Medicines. Thus, as the need for this industry grows, so does the share’s potential for future profit.

You are welcome to share this website if you believe it will be useful to you. Please use the comment box to ask any questions you may have, and we will do our best to address them and find a solution. We appreciate you coming to our website and staying with us.

Disclaimer

The above-mentioned Gland Pharma share price targets are for reference purposes only and are not assured to remain accurate. They are dependent upon favorable market circumstances, company performance, and other variables. They are predicated on the assumption of a favorable market. Always conduct your research and consult with a financial advisor before making investment decisions. Past performance does not always guarantee future results.